Medical technology company, Terumo Aortic has announced a European limited release of its RelayPro Thoracic Stent-Graft System.
Terumo Aortic
Announced at the 2018 Charing Cross conference, RelayPro is a low-profile device designed to expand the treatment of thoracic endovascular aortic repair (TEVAR) to patients with smaller access vessels.
The device utilises the same stent design, material, and dual sheath technology of the company’s RelayPlus. The device is designed to offer physicians a wide range of diameters, lengths, tapers, and proximal configurations and can be individualised to meet the specific anatomical needs of patients.
Mark Miles, global vice president of marketing at Terumo Aortic, said: “By combining the proven stent design and material of RelayPlus with a lower outer profile. RelayPro enables percutaneous access to treat a larger patient population. This advancement not only expands patient applicability but will help improve access site complications and ultimately reduce the burden of rising global healthcare costs.”
RelayPro is currently undergoing multiple trials in US and Japan for treatment of descending thoracic aortic aneurysms, acute complicated type B thoracic aortic dissection, and blunt aortic trauma.
